New York City issues Health Advisory about overdoses from fentanyl added to cocaine

Post Date: 
June 6 2017

Gulf Coast HIDTA and the Georgia Bureau of Investigation Issue Synthetic Opioids Alert

Post Date: 
May 16 2017

Fake Prescription Drugs Laced with Fentanyl

Post Date: 
May 5 2016

Teen Opioid Prescriptions Raise Risk of Later Opioid Misuse

A new study using data from the NIDA-funded Monitoring the Future survey of adolescent drug use and attitudes conducted annually by the University of Michigan shows that teens who received a prescription for opioid pain medication by Grade 12 were at 33 percent increased risk of misusing an opioid between ages 19 and 25.

December 2015

Communities that implemented Life Skills Training in a trial more than recouped its cost in reduced health, social, and other expenditures related to teen prescription opioid misuse.

November 2015

In the first long-term follow-up of patients treated with buprenorphine/naloxone for addiction to opioid pain relievers, half reported that they were abstinent from the drugs 18 months after starting the therapy.

FDA approves naloxone nasal spray to reverse opioid overdose

The new technology has an easy-to-use, needle-free design, providing family members, caregivers and first responders with an alternative to injectable naloxone for use during a suspected opioid overdose.

NIDA redesigns Easy to Read and Learn the Link websites for mobile devices

This new responsive design model automatically adjusts each page to fit the viewer’s screen for faster and easier viewing and navigation on a variety of mobile platforms, such as smartphones and tablets.

Nasal spray naloxone one step closer to public availability

The National Institute on Drug Abuse (NIDA) is pleased to announce that Adapt Pharma Limited, a partner of Lightlake Therapeutics Inc., has commenced a rolling submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA) for a nasal spray formulation of naloxone, a drug designed to prevent opioid overdose deaths.

Prescribing lifesaving naloxone: Addressing attitudes of primary care clinicians

NIDA-funded research exploring barriers to prescribing naloxone, a safe, easy-to-use drug that can prevent opioid overdose deaths, suggests that primary healthcare providers have limited knowledge about it, and have concerns about its misuse and safety.